Venrock Healthcare Capital Partners III, L.P. 13D and 13G filings for CytomX Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-20 4:25 pm Purchase | 2025-05-13 | 13G | CytomX Therapeutics, Inc. CTMX | Venrock Healthcare Capital Partners III, L.P. | 12,992,500 8.200% | 12,992,500 (New Position) | Filing |